Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease

ClinicalTrials.gov ID: NCT00002244

Public ClinicalTrials.gov record NCT00002244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pivotal Clinical Study Evaluating the Safety and Efficacy of WF10 (TCDO) Intravenous Solution in the Management of Patients With Late-Stage HIV Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to see if it is safe and effective to give WF10 to adults with late-stage HIV disease. WF10 is suspected to help the immune system fight infection and slow HIV disease progression.

Study identification

NCT ID
NCT00002244
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
OXO Chemie
Industry
Enrollment
240 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
23
Facility City State ZIP Site status
Univ of Alabama at Birmingham Birmingham Alabama 35294 —
Tower Infectious Disease Med Ctr Los Angeles California 90048 —
Highland Gen Hosp / San Francisco Gen Hosp Oakland California 946021018 —
ViRx Inc San Francisco California 94103 —
UCSF - San Francisco Gen Hosp San Francisco California 94110 —
George Washington Univ Med Ctr Washington D.C. District of Columbia 20037 —
Univ of Miami School of Medicine Miami Florida 33136 —
Hillsborough County Health Dept Tampa Florida 33602 —
Ctr for Quality Care Tampa Florida 33609 —
AIDS Research Consortium of Atlanta Atlanta Georgia 30308 —
Leahi Hosp / Univ of Hawaii Honolulu Hawaii 96816 —
Northwestern Univ Med School Chicago Illinois 60611 —
Rush Med Ctr / Section of Infectious Diseases Chicago Illinois 60612 —
The CORE Ctr Chicago Illinois 60612 —
Univ of Iowa Hosp & Clinic Iowa City Iowa 52242 —
Boston Med Ctr / Clinical Research Office Boston Massachusetts 02118 —
Univ Health Ctr Detroit Michigan 48201 —
Regions Hosp Saint Paul Minnesota 55101 —
Truman Med Ctr / Infectious Disease Clinic Kansas City Missouri 64108 —
Newark Community Health Ctr Newark New Jersey 07114 —
Univ of New Mexico Health Science Center Albuquerque New Mexico 87131 —
Associates in Med and Mental Health Tulsa Oklahoma 74114 —
MCP Hahnemann Univ Philadelphia Pennsylvania 19102 —
Ludwig Lettau Private Practice Charleston South Carolina 29414 —
Burnside Clinic Columbia South Carolina 29206 —
Hampton Roads Med Specialists Hampton Virginia 23666 —
Virginia Mason Research Center / Clinical Trial Unit Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →